GlassScriptPhysician profile
Jean O Ung
NPI 1316908312
$17,172.62
in general payments reported to CMS, 2019-2025
39 companies · $1,450 in 2025
The $1,450 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $501 · 2020: $580 · 2021: $4,969 · 2022: $1,586 · 2023: $2,463 · 2024: $5,625 · 2025: $1,450.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,436 · Consulting Fee: $2,754 · Education: $233 · Travel and Lodging: $114.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,436.47 |
| Consulting Fee | $2,754.00 |
| Education | $232.99 |
| Travel and Lodging | $114.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Karl Storz Endoscopy-America | $7,852.11 | 2019-2024 | Flex-X, Hopkins |
| Astellas Pharma US INC | $1,524.23 | 2019-2025 | Xtandi, Myrbetriq |
| Sumitomo Pharma America, INC. | $1,381.98 | 2023-2025 | Gemtesa, Orgovyx |
| Axonics, INC. | $862.47 | 2022-2024 | Bulkamid, Axonics |
| Abbvie INC. | $790.71 | 2022-2025 | Botox |
| Urovant Sciences INC | $480.48 | 2021-2022 | |
| Olympus America INC. | $361.45 | 2020-2025 | Itind System, Soltive |
| Pfizer INC. | $327.61 | 2019-2024 | |
| Coloplast Corp | $327.56 | 2022-2025 | Speedicath |
| Bayer Healthcare Pharmaceuticals INC. | $310.83 | 2021-2024 | |
| Urogen Pharma, INC. | $231.32 | 2023-2025 | Jelmyto |
| Neotract INC. | $220.78 | 2020 | |
| Procept Biorobotics Corporation | $195.35 | 2023-2024 | Aquabeam System, Aquabeam Robotic System |
| Teleflex LLC | $190.67 | 2021-2024 | Urolift |
| Boston Scientific Corporation | $179.26 | 2019-2025 | Axonics |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Calyxo, INC. | $137.59 | 2024-2025 | Cvac Aspiration System |
| Ferring Pharmaceuticals INC. | $136.39 | 2024-2025 | Adstiladrin |
| Bluewind Medical | $133.68 | 2024 | Revi |
| C. R. Bard, INC. & Subsidiaries | $122.51 | 2019-2025 | Bard Urinary Drainage Bag |
| Tolmar, INC. | $111.19 | 2023-2024 | |
| Astrazeneca Pharmaceuticals LP | $110.44 | 2024 | Lynparza |
| Endo Pharmaceuticals INC. | $109.86 | 2019-2023 | Edex, Xiaflex, Aveed |
| Karl Storz Lithotripsy-America | $104.25 | 2020 | |
| 180 Medical, INC. | $97.28 | 2022-2025 | Gentlecath Glide, Cure Catheter |
| Becton, Dickinson and Company | $96.37 | 2022-2025 | Bard Urinary Drainage Bag |
| Myovant Sciences INC. | $91.12 | 2022 | |
| Laborie Medical Technologies Corp. | $91.07 | 2022 | |
| Blue Earth Diagnostics | $90.33 | 2024 | |
| Progenics Pharmaceuticals, INC. | $78.25 | 2025 | |
| Halozyme INC | $75.23 | 2023 | |
| Endo USA, INC. | $73.06 | 2024-2025 | Xiaflex |
| Allergan, INC. | $59.73 | 2019-2020 | |
| Dendreon Pharmaceuticals LLC | $53.08 | 2025 | Provenge |
| Janssen Biotech, INC. | $46.52 | 2024-2025 | Erleada |
| Mission Pharmacal Company | $32.62 | 2022-2023 | Uribel |
| Antares Pharma, INC. | $32.26 | 2024-2025 | Xyosted |
| Convatec INC. | $19.79 | 2022 | |
| Lantheus Medical Imaging, INC. | $19.39 | 2024 | |
| Hollister Incorporated | $13.80 | 2023 | Onli, Infyna Chic, Vapro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jean Ung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.